Organon & Co.
OGN
Market Cap$5.61B
Close$
$38.19
75.2% upside
Current Fair Value
75.2% upsideUndervalued by 75.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.61 Billion |
|---|---|
| Enterprise Value | $13.75 Billion |
| Dividend Yield | $1.0935 (5.02%) |
| Earnings per Share | $4.08 |
| Beta | 0.0 |
| Outstanding Shares | 257,170,727 |
| Avg 30 Day Volume | 2,307,086 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 5.35 |
|---|---|
| PEG | 39.49 |
| Price to Sales | 0.91 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.17 |
| Enterprise Value to EBIT | 10.2 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.63 |
| Debt to Equity | 181.54 |
Revenue Sources
No data
ESG Score
No data